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Hyaluronic acid-carboxymethylcellulose
reduced postoperative bowel adhesions
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surgery: a prospective, randomized,
controlled, single-blind study
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Abstract
Background: To assess the anti-adhesive effect of treatment with hyaluronic acid-carboxymethylcellulose following
laparoscopic radical prostatectomy.
Methods: This was a randomized, controlled, single-blind, parallel-group study using hyaluronic
acid-carboxymethylcellulose in patients who underwent laparoscopic radical prostatectomy. Sixty patients were
enrolled in the study. All patients were randomly assigned to either the hyaluronic acid-carboxymethylcellulose
treatment group (n = 30) or the control group (n = 30). Viscera slide ultrasounds and plain X-rays were obtained at
enrollment (V0), postoperative week 12 (V1), and 24 (V2). The primary end point was the difference in the excursion
distance in the viscera slide ultrasound between V0 and V2.
Results: A total of 50 patients completed this study. The average excursion distance at V2 in the experimental
group (n = 25) was significantly longer than in the control group (n = 25, 2.7 ± 1.2 vs. 1.3 ± 1.0 cm, respectively;
p < 0.001). The differences in the V0 and V2 excursion distances were significantly higher in the control group
than in the experimental group (1.48 ± 1.5 vs. 2.9 ± 1.2 cm, respectively; p < 0.001). None of patients showed
adverse events associated with the use of hyaluronic acid-carboxymethylcellulose.
Conclusion: This randomized study demonstrated that hyaluronic acid-carboxymethylcellulose treatment
resulted in a reduction in bowel adhesion to the abdominal wall after laparoscopic pelvic surgery and had
good clinical safety.
Trial registration: ClinicalTrials.gov Identifier: NCT02773251 Date: May 12, 2016.
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Background
Postoperative adhesions frequently occur following abdom-
inal surgery [1, 2]. Peritoneal adhesions are a consequence
of surgical trauma such as dissection, cutting, and coagula-
tion, and can result in adhesion-related complications that
can increase health care costs. To date, there no effective
treatments for adhesions have been developed. Thus, the
prevention and reduction of adhesions is the best manage-
ment strategy [3].
Many researchers have been trying to find effective
methods to prevent adhesions, and various barrier ma-
terials have been developed and studied. Individual
studies with barrier materials have reported positive re-
sults in the prevention of postoperative adhesions [4, 5].
However, another study on barriers did not demonstrate
efficacy in reducing adhesions [6]. A meta-analysis from
28 trials (5191 patients) reported that oxidized regener-
ated cellulose and Hyaluronic acid-carboxymethylcellulose
(HA/CMC) can safely reduce the clinically relevant conse-
quences of adhesions [7]. Most of the trial agents evalu-
ated in the above studies were based on open bowel
surgery. Recently, laparoscopic surgery has been expand-
ing rapidly and has gained acceptance as a viable alterna-
tive to traditional open surgery [8]. A certain degree of
peritoneum loss should be also inevitable during laparo-
scopic pelvic surgery (i.e., laparoscopic radical prostatec-
tomy and cystectomy), although the loss of peritoneum
should be smaller than open surgery.
There are a few studies based on patients who have
undergone laparoscopic surgery [5, 9, 10], but no study
has targeted laparoscopic urologic surgery. In addition,
these studies did not directly assess the presence of ad-
hesions. The purpose of this study was to assess the
presence of adhesions as determined by viscera slide
ultrasound after treatment with HA/CMC following
laparoscopic radical prostatectomy.
Methods
This was a prospective, randomized, controlled, single-
blind, parallel-group study using HA/CMC (marketed
as Guardix-sol®, Hanmi Medicare, Seoul, Korea) in pa-
tients who underwent laparoscopic radical prostatec-
tomy between November 2011 and June 2014. All the
patients were informed in detail about the aims and the
procedures of the study and they signed a written in-
formed consent prior inclusion into the study. The
protocol and the written informed consent were approved
by the local ethical committee (Catholic Medical Center,
Clinical Research Coordinator Center; approval number
XC11DIMI10098H).
Subjects
Men who were 50–75 years old and diagnosed with
prostate cancer were eligible if they were scheduled to
undergo laparoscopic radical prostatectomy. Exclusion
criteria included any history of abdominal or pelvic
surgery, hypersensitivity or an allergic reaction to the
study material, pelvic lymph node dissection at the
same time as prostatectomy, the presence of surgical
site infection or contamination, a history of a medical
disease causing bowel adhesion, or a history of severe
drug allergies.
Study design and protocol
The laparoscopic radical prostatectomy was performed
in same surgical procedures and steps by two surgeons
(USH and JSK) who have experienced over 150 cases of
laparoscopic radical prostatectomy. The laparoscopic
radical prostatectomy was performed using the five-
port fan-shaped transperitoneal approach. After the
introducing the peritoneal cavity, incising the parietal
peritoneum between the medial umbilical ligaments are
incised and dissection is carried through the fatty alveo-
lar tissue to develop the space of Retzius. After that,
the surgical steps are following order (1) incision of the
endopelvic fascia; (2) ligation of the dorsal vein com-
plex; (3) division of the bladder neck; (4) dissection of
the seminal vesicles; (5) incision of the Denonvillier
fascia and control of the lateral pedicles with antegrade
neurovascular bundle dissection; (8) apical dissection
and division of the dorsal vein and the urethra; (9) ure-
throvesical anastomosis.
Considering about 30 % of dropout rate (under the
assumption of 40 % difference between HA/CMC treat-
ment group and the control group based on previous
similar study10), by which the target enrollment for this
trial was 60 subjects (30 subjects per group). The sam-
ple size was determined assuming a level of significance
of α = 0.05 (two-side) and a 80 % statistical power of
test. All patients were randomly assigned to either the
HA/CMC treatment group (n = 30) or the control group
(n = 30) using a computer-generated randomization table.
The surgeon was blinded to treatment assignments
before randomization. Patients were also blinded to
their treatment group throughout the study. HA/
CMC was applied in all port sites and the peritoneal
incision line of the medial umbilical ligament with a
single-use applicator attached to a sprayer that allowed for
the precise application to the required sites (Fig. 1). The
amount of HA/CMC applied was 5 ml. Information re-
garding the duration of illness and medical history were
collected at the time of enrollment (V0). Viscera slide
ultrasound and plain X-ray were recorded at the time
of the operation (V0) and 12 (V1) and 24 week (V2)
after the operation.
The primary end point was the difference in excursion
distance on viscera slide ultrasound between V0 and V2.
The secondary end point was excursion distance on
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viscera slide ultrasound at V2 and the presence of
restriction of viscera slide on ultrasound at V2.
Assessment of efficacy and safety
Twelve and 24 weeks after the operation, bowel adhe-
sion to the abdominal wall was evaluated by ultrasound
and plain X-rays. We performed viscera slide ultrasound
according to a technique that has been previously de-
scribed [11]. By dividing the abdomen into 5 segments
and examining the viscera slide in each segment, a pre-
diction of the extent of the adhesions was made for
each patient. Figure 2 shows the division of the abdo-
men into 5 segments and their numbering. At the time
of the viscera slide ultrasound, data were also collected
on the location of the scars on the abdomen. The main
point of interest was the distance of the longitudinal
excursion of the selected area in relation to the fixed
abdominal wall. Normal viscera sliding movement was
defined as equal to or greater than 1 cm of longitudinal
movement. Restricted viscera slide was defined as less
than 1 cm of longitudinal movement during both nor-
mal and exaggerated respiration. The ultrasound was
performed by two sonographers who had been well
instructed for study assessment. The assessment by
ultrasound was double-checked. The sonographer, radi-
ologist and all accessor was blind to the randomization
during the all study period.
Statistical analysis
The data for this study are expressed as mean ± standard
deviation of the mean. The comparisons of the 2 groups
were made using a χ2 test, an independent Student’s t
test, or repeated measure ANOVA. P-values <0.05 were
considered significant. Statistical calculations were car-
ried out with IBM SPSS statistics, Version 21 (IBM
Corp, Armonk, NY).
Results
A total of 60 patients who diagnosed with prostate can-
cer were enrolled and 50 patients completed this study.
In the HA/CMC group, two patients were lost to follow-
up, two patients dropped out because they don’t want to
undergo a sonography test and one patient was switched
to open radical prostatectomy. In the control group, two
patients were lost to follow-up and three patient
dropped out because they don’t want to undergo a son-
ography test. The characteristics of the patients who
completed the study are summarized in Table 1. There
were no statistically significant differences in the base-
line characteristics between groups. There were also no
differences in the perioperative findings between groups
(Table 2), nor were there any differences in the number
of ports used for each patient (5 ports), the size of the
ports (1.1 cm), or the site of insertion. None of the
patients enrolled in this study showed postoperative
complications such as wound infections, bladder ureth-
ral anastomosis leakage, post-operative ileus, or adverse
events (e.g. hypersensitivity or an allergic reaction) asso-
ciated with the use of HA/CMC.
Table 3 shows the results of the adhesion characteris-
tics in the experimental and control groups. The average
post-operative excursion distance in the experimental
group (2.7 ± 1.2 cm) was significantly longer than that of
the control group (1.3 ± 1.0 cm; p < 0.001). The differences
in the V0 and V2 excursion distances were significantly
higher in the control group (2.9 ± 1.2 cm) than in the ex-
perimental group (1.48 ± 1.5 cm; p < 0.001).
According to the restriction criteria, a total of 43 sites
showed visceral slide restriction in the experimental
group, while a total of 74 sites in the control group
Fig. 2 Map of the abdomen divided into 5 segments by bilateral,
vertical, and proximal one-third clavicular lines, a transverse line
across the supraumbilical region, and a transverse line across the
anterior superior iliac spines
Fig. 1 A view of HA/CMC application: HA/CMC was applied to the port
site and peritoneal incision line of the medial umbilical ligament with a
single-use applicator
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showed restriction, which was a significant difference.
Plain X-rays showed an ileus gas pattern in patients in
both groups (experimental group: 8 % [2/25], control
group: 16 % [4/25]), but none of the participants com-
plained of abdominal pain.
Discussion
The main findings of this study are that HA/CMC treat-
ment increased bowel excursion distance in patients
after laparoscopic pelvic surgery, suggesting that it re-
duced and prevented bowel adhesion to the damaged
layer between anterior abdominal wall and peritoneum
including port site. Furthermore, there were no reports
of complications associated with the use of HA/CMC.
The key sites of adhesion formation are the port sites
and damaged surface lining of the peritoneum between
the medial umbilical ligaments. The peritoneal injury be-
tween anterior abdominal wall and anterior peritoneum,
which is inevitable, can cause a local inflammatory
reaction with fibrous exudate and fibrin formation.
Various factors can lead to postoperative adhesions, in-
cluding the type and technique of surgery, individual
predisposing factors, thermal injury, trauma, and a his-
tory of previous surgery. The balance between fibrin
deposition and degradation is crucial in determining
whether normal peritoneal healing or adhesion formation
occurs, with peritoneal injury promoting an imbalance
in fibrin kinetics which may serve as a scaffold for fi-
broblasts and capillary in-growth that form peritoneal
adhesions [12]. Keeping peritoneal surfaces separate for
peritoneal re-epithelialization is critical for preventing
and decreasing adhesion.
Adhesive strength that can withstand gravity is con-
sidered to be an important factor for measuring success
because the target site in this study is the abdominal
wall. Park et al. conducted a study using Seprafilm® (a
hyaluronate/carboxycellulose-based membrane) and
found that this membrane type was brittle and difficult
to apply, with liquid devices likely to be more useful in
this setting [13]. Another animal study showed that a
liquid device appeared to be superior to Seprafilm®
[14]. The idea of using HA/CMC gel to reduce bowel
adhesions to the abdominal wall was based on its rela-
tively high adhesive strength, and previous studies have
demonstrated a significant reduction of post-surgical
adhesions after the instillation of HA/CMC solutions
as tissue barriers during the healing process [15–17].
HA/CMC, which is a liquid-type synthetic physical
sol–gel barrier with a viscosity ranging from 2500 to
3500 cP, is an anionic polysaccharide that is composed
of D-glucuronic acid and N-acetyl-D-glucosamine [15].
Thus, HA/CMC is sticky and coats the peritoneum for
a sufficient period and make up damage when it is
sprayed on the tissue [18]. In addition to physical barrier
to maintain a space, HA/CMC can reduce inflammation
by preventing the migration of leukocyte and fibroblasts
to the operation site. Sohn et al showed in his experimen-
tal study that HA/CMC treatment significantly decrease
average degrees of polymorphonuclear leukocyte and
myofibroblasts infiltration [19].
In the present study, our results showed significantly
increased bowel excursion distance in the treatment
group as compared to the control group. The fact that
patients treated with HA/CMC had reduced postopera-
tive bowel adhesions to the abdominal wall can be at-
tributed to the extended presence of the barrier and the
maintenance of coating activity between the abdominal
wall and bowel.
One distinctive feature of this study is its examination
of the prevention of adhesions in laparoscopic pelvic
surgery in the urologic field. This study is the first clin-
ical report to evaluate the efficacy of strategies to
Table 2 Operative and post-operative clinical data in the


















Total operative surgical time
(min), mean ± SD
214.7 ± 82.5 202.1 ± 92.6 0.212
Estimated blood loss (ml) 158.8 ± 120.7 173.9 ± 113.5 0.382
Table 1 Demographic data of the Hyaluronic acid-






Age (years), mean ± SD 67.5 ± 9.3 65.4 ± 10.5 0.542
BMI (kg/m2), mean ± SD 24.7 ± 2.9 25.1 ± 2.6 0.453
Combined disease, n (%)
DM 6 4 0.480









1 14 17 0.382
2 11 8
3–6 0 0
BMI body mass index, DM diabetes mellitus, ASA American Society
of Anesthesiologists
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prevent adhesions to the abdominal wall, such as at the
port site and the incision line of the medial umbilical
ligament, in patients who have undergone laparoscopic
radical prostatectomy. Most previous studies evaluating
the use of HA/CMC have been conducted with open
surgery. The fact that minimally invasive surgeries such
as laparoscopic or robot-assisted laparoscopic surgery
have become more popular in pelvic surgery without
bowel resection and manipulation could affect the effi-
cacy of HA/CMC as compared to previous studies.
Thus, we conducted a study targeting patients who
have undergone laparoscopic radical prostatectomy.
Another unique feature of this study is that we used
ultrasonic detection and mapping of abdominal wall
adhesions as an evaluation method, which was devel-
oped by Sigel B et al [11]. Although adhesions are the
main cause of small bowel obstruction and ileus, post-
operative adhesions do not always result in bowel ob-
struction, especially when pelvic surgery is performed
without bowel resection or manipulation. Bowel adhe-
sion to the abdominal wall is expected to be one of the
most frequent sites of adhesion in patients who have
undergone surgery without bowel resection or manipu-
lation. This means that the presence of adhesions
cannot be fully assessed by plain x-ray or by clinical
history in patients who have undergone surgery with-
out bowel resection or manipulation. Ultrasound exam-
ination is a specific and reliable method to identify and
detect adhesion-free areas [20, 21]. Previous studies
have relied on second-look operations for the evalu-
ation of post-operative adhesions, which is invasive and
cannot be used to evaluate all patients who have had
surgery. We selected ultrasound as an evaluation
method to specifically evaluate adhesions between the
abdominal wall and bowel.
This study had a relatively small sample size, resulting
in limitation of its statistical power. Another initial
concern was a lack of interest among patients to be en-
rolled in the control group because many wanted to be
treated with HA/CMC. These data and results must be
considered as a preliminary report, although the fact
that these findings were statistically significant should
be noted.
Conclusions
This randomized study provided preliminary data demon-
strating that HA/CMC treatment resulted in a reduction in
bowel adhesion to the abdominal wall after laparoscopic
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Table 3 Adhesion characteristics in the Hyaluronic acid-carboxymethylcellulose (HA/CMC) group and the control group
HA/CMC group (n = 25) Control group (n = 25) p-value
V0 (0 week) V2 (24 weeks) p-value V0 (0 week) V2 (24 weeks) p-value
Ultrasound findings
Average excursion distance of the viscera slide 4.2 ± 0.6 2.7 ± 1.2 <0.001a 4.1 ± 0.7 1.3 ± 1.0 <0.001a
Difference in V0 and V2 1.48 ± 1.5 2.9 ± 1.2 <0.001b
% of restricted viscera slide sites 0 34.4 (43/125) 0 59.2 (74/125) <0.001c
aindependent t-test, brepeated measure ANOVA, cχ2 test
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